Life SciencesLiability
Get a quote

TL;DR

The Dallas-Fort Worth metroplex has a fast-growing life-sciences cluster anchored by UT Southwestern Medical Center and the Pegasus Park hub, spanning biotech, medical device, pharma, and contract manufacturing. Programs here are built around the operator's sub-vertical - D&O and clinical trial liability for clinical-stage biotech, products liability for device makers, and sponsor MSA and hospital contract compliance for manufacturers - placed through A-rated specialty markets. Life Sciences Liability is a Texas-based practice serving DFW operators across all of these.

Dallas & Fort Worth life sciences

Dallas life sciences insurance - the DFW biotech, device, and pharma cluster.

Dallas-Fort Worth is one of the fastest-growing life-sciences markets in the country. UT Southwestern Medical Center anchors the research core, the Pegasus Park campus (home to the BioLabs incubator) has become a magnet for early-stage biotech, and the wider metroplex spans clinical-stage drug developers, medical device and ophthalmic companies in Fort Worth, and healthcare and distribution giants. That range means a Dallas life-sciences operator can look nothing like the one next door - and neither should its insurance program.

The right coverage for a DFW life-sciences company is driven by what it actually does. A UT Southwestern biotech spinout, a Fort Worth device manufacturer, and a Dallas-area contract manufacturer each face a different risk architecture and different contract requirements. As a Texas-based specialty practice, we build the program around the operator's sub-vertical and the sponsor, hospital, and licensing contracts it signs, rather than a one-size-fits-all package.

Get a quoteRun the Free Analyzer

Last updated 2026-07-14

Cluster shape

A research core with a broad commercial and device periphery.

UT Southwestern Medical Center is the research engine of the cluster, producing the academic science and spinouts that seed DFW biotech. Clinical-stage drug developers in the metroplex - including gene-therapy and specialty-pharma operators with UT Southwestern roots - carry the biotech risk profile: D&O mandatory once outside investor capital arrives, clinical trial liability per active trial, cyber sized to clinical and drug-master-file data, and academic-license indemnity flowing back to the institution.

Fort Worth adds a genuine medical device and eye-care/dermatology manufacturing presence, where the program shifts to products liability sized to device class, IDE clinical trial coverage, product recall, and the hospital purchase-contract and GPO supplier requirements that come with selling into health systems.

The broader metroplex rounds out the cluster with pharmaceutical and contract-manufacturing operations and the healthcare and distribution companies headquartered in the region. For manufacturers and CDMOs, the program centers on cGMP property, products and completed-operations liability, and the sponsor MSA insurance schedules that govern the work.

Coverage architecture

The program follows the sub-vertical, not a generic package.

For clinical-stage biotech, the load-bearing lines are D&O (Series A-C typically $1M-$15M, stepping up toward IPO readiness), clinical trial liability sized per trial, cyber for clinical PHI and drug-master-file data, and IP infringement defense for platform IP. Products liability activates near commercial launch, not at IND.

For medical device manufacturers, products liability is the core line, sized to device class (Class I/II/III), with IDE clinical trial coverage during studies, product recall as a separate first-party trigger, and additional-insured for products and completed operations to satisfy hospital and GPO purchase contracts. Software-driven devices add cyber and technology E&O.

For contract manufacturers and pharma operators, the program is built around cGMP-aligned property with validation-loss coverage, products and completed-operations liability, cargo for material in custody, and the sponsor MSA insurance schedules that drive additional-insured, primary and non-contributory, and limits requirements. The common thread across all three is that the contract, not a template, sets the requirement.

Regulatory + market context

A Texas-based practice on home turf.

Texas is a deep, business-dense insurance market with strong surplus-lines availability for specialty life-sciences risks, and DFW's growth as a life-sciences hub means the sub-vertical exposures - biotech D&O, device products, and manufacturing - are all present in the metroplex. Each is underwritten as a class first and a location second, but the contracts a DFW operator signs (sponsor MSAs, hospital purchase contracts, UT Southwestern and other academic licenses) are where placements succeed or fail.

Life Sciences Liability is a Texas-based specialty practice, which means the DFW sponsor MSA, GPO supplier, and hospital purchase-contract schedules that drive these programs are exactly the documents the MSA Decoder workflow is built to translate. Building the program around those contracts, ahead of the next milestone, is what keeps a Dallas operator both covered and contract-eligible.

Frequently asked

Common questions from Dallas life sciences operators

What makes Dallas life sciences insurance different from a generic business policy?

A DFW life-sciences operator faces sub-vertical-specific exposures a generic package does not contemplate: clinical trial liability and D&O for biotech, products liability and hospital/GPO additional-insured for device makers, and cGMP property and sponsor MSA compliance for manufacturers. The right program is built around what the company actually does and the contracts it signs (sponsor MSAs, hospital purchase contracts, UT Southwestern and other academic licenses), not a one-size-fits-all business owners policy.

What coverage does a UT Southwestern biotech spinout need?

A clinical-stage DFW biotech spinout typically needs D&O (mandatory once outside investor capital arrives, commonly $1M-$15M through Series A-C and stepping up toward IPO), clinical trial liability sized per active trial, cyber sized to clinical PHI and drug-master-file data, IP infringement defense for platform IP, and academic-license indemnity naming UT Southwestern as additional insured. Products liability is kept minimal until commercialization approaches.

How is a Fort Worth medical device manufacturer covered?

Products liability is the core line, sized to device class, with IDE clinical trial coverage during investigational studies and product recall as a separate first-party trigger. Selling into hospitals and health systems means meeting purchase-contract and GPO supplier requirements - additional-insured for products and completed operations, primary and non-contributory wording, and specified limits. Software-driven devices add a cyber and technology E&O layer.

Does being a Texas-based practice help a Dallas operator?

It means the DFW sponsor MSAs, hospital purchase contracts, GPO supplier agreements, and academic licenses that drive these programs are the documents we work with every day, and the free MSA Decoder is built to translate them clause by clause. The program is built around the operator's actual contracts and sub-vertical, placed through A-rated specialty markets, with an end-of-day response on review requests.

Life sciences insurance practice →Medical device insurance →Biotech insurance →DFW CDMO insurance →

Free coverage review

A specialist will reach out by end of business day.

Programs placed through A-rated specialty markets. Send your contract, insurance schedule, or current COI - a specialist returns a clause-by-clause read by end of business day.

Get my quote

Specifically for Dallas life sciences operators.

Programs placed through A-rated specialty markets. Your specialist handles unlimited certificates of insurance, annual coverage reviews, and claims advocacy.